The bill strengthens U.S. tools to expose and punish alleged involuntary organ harvesting in China and protects humanitarian aid and business certainty, but it risks straining U.S.–China relations, limiting research collaboration, imposing compliance costs, and curbing some policy levers like import sanctions.
U.S. policymakers and the public gain stronger tools to hold individuals and entities tied to alleged involuntary organ harvesting in China accountable (targeted asset blocks, sanctions, and visa restrictions), increasing deterrence and signaling consequences.
U.S. diplomats and agencies receive a unified, evidence-based report and clearer authority for coordinated action, improving policymaking, congressional oversight, and cooperation with allies to raise international pressure on human-rights abuses.
Humanitarian transactions (food, medicine, and vital assistance) are explicitly exempted, protecting NGOs and ensuring continued delivery of humanitarian aid despite sanctions provisions.
U.S.–China diplomatic relations and cooperation on trade, climate, and security could be strained as a result of sanctions, public reporting, and raised allegations, potentially reducing U.S. influence and complicating negotiations.
Individuals and entities can be barred from U.S. visas and admissions (and have assets blocked) based on listings in the law, which can impede family travel, diplomacy, and business before judicial findings.
Restrictions, public listings of past grants, and limits on cooperation could slow medical and research collaborations with Chinese institutions, interrupt ongoing projects, and impede scientific progress.
Based on analysis of 6 sections of legislative text.
Directs U.S. policy to avoid cooperation with China on organ transplants, authorizes targeted sanctions and visa bans for those tied to forced organ harvesting, and requires a detailed report on China’s transplant practices.
Introduced March 3, 2025 by Rafael Edward Cruz · Last progress March 3, 2025
Creates a U.S. policy to avoid cooperation with China on organ transplantation and to use targeted measures — including sanctions and visa restrictions — against foreign persons the President determines knowingly engaged in or facilitated involuntary organ harvesting in the People’s Republic of China. It also requires a detailed interagency report on China’s transplant system, limits the scope of allowable sanctions (excluding bans on imports), and sets timelines for lists, reports, waivers, and expiration of the sanction authority.